Candel Therapeutics, Inc. CADL Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s quick ratio?
- Candel Therapeutics, Inc. (CADL) reported quick ratio of 28× in Q1 2026.
- How has Candel Therapeutics, Inc.'s quick ratio changed year-over-year?
- Candel Therapeutics, Inc.'s quick ratio increased by 504.3% year-over-year, from 4.6× to 28×.
- What is the long-term trend for Candel Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s quick ratio has grown at a 12.6% compound annual growth rate (CAGR), from 7.5× to 13.5×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.